Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 Å resolution

Structure

Volumn 6, Issue 11, 1998, Pages 1383-1393

  Ultsch, Mark ^a   Lokker, Nathalie A ^a,b   Godowski, Paul J ^a   De Vos, Abraham M ^a  

^a GENENTECH INC   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

Heparin binding; Hepatocyte growth factor; Kringle; N domain; Receptor binding

Indexed keywords

EID: 0032533765     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(98)00138-5     Document Type: Article

References (51)

1. Michalopoulos, G., Houck, K.A., Dolan, M.L. & Luetteke, N.C. (1984). Control of hepatocyte replication by two serum factors. Cancer Res. 44, 4414-4419.
2. Nakamura, T., Nawa, K. & Ichihara, A. (1984). Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 122, 1450-1459.
3. Igawa, T., et al., & Nakamura, T. (1991). Hepatocyte growth factor is a potent mitogen for cultured rabbit renal tubular epithelial cells. Biochem. Biophys. Res. Commun. 174, 831-838.
4. Kan, M., et al., & Stevens, J.I. (1991). Hepatocyte growth factor/hepatopoietin A stimulates the growth of rat kidney proximal tubule epithelial cells (RPTE), rat nonparenchymal liver cells, human melanoma cells, mouse keratinocytes and stimulates anchorage-independent growth of SV-40 transformed RPTE. Biochem. Biophys. Res. Commun. 174, 331-337.
5. Matsumoto, K., Tajima, H. & Nakamura, T. (1991). Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth. Biochem. Biophys. Res. Commun. 176, 45-51.
6. Rubin, J.S., et al., & Aaronson, S.A. (1991). A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc. Natl Acad Sci. USA 88, 415-419.
7. Stoker, M., Gherardi, E., Perryman, M. & Gray, J. (1987). Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327, 239-242.
8. Weidner, M.K., Behrens, J., Vandekerckhove, J. & Birchmeier, W. (1990). Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J. Cell Biol. 111, 2097-2108.
9. Naldini, L., et al., & Comoglio, P.M. (1991). Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J. 10, 2867-2878.
10. Montesano, R., Matsumoto, K. & Nakamura, T. (1991). Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67, 901-908.
11. Naldini, L., et al., & Comoglio, P.M. (1991). Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene 6, 501-504.
12. Bottaro, D.P., et al., & Aaronson, S.A. (1991). Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251, 802-804.
13. Park, M., Dean, M., Kaul, K., Braun, M.J., Gonda, M.A. & Vande Woude, G. (1987). Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth factors. Proc. Natl Acad. Sci. USA 84, 6379-6383.
14. Zioncheck, T.F., et al., & Stack, R.J. (1995). Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity. J. Biol. Chem. 270, 16871-16878.
15. Ornitz, D.M., Herr, A.B., Nilsson, M., Westman, J., Svahn, C.-M. & Waksman, G. (1995). FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides. Science 268, 432-436.
16. Faham, S., Hileman, R.E., Fromm, J.R., Linhardt, R.J. & Rees, D.C. (1996). Heparin structure and interactions with basic fibroblast growth factor. Science 271, 1116-1120.
17. Miyazawa, K., et al., & Kitamura, N. (1989). Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem. Biophys. Res. Commun. 163, 967-973.
18. Nakamura, T., et al., & Shimuzi, S. (1989). Molecular cloning and expression of human hepatocyte growth factor. Nature 342, 440-443.
19. Donate, L.E., Gherardi, E., Srinivasan, N., Sowdhamini, R., Aparicio, S. & Blundell, T.L. (1994). Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP). Protein Sci. 3, 2378-2394.
20. Lokker, N.A., et al., & Godowski, P.J. (1992). Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding. EMBO J. 11, 2503-2510.
21. Miyazawa, K., Kitamura, A., Naka, D. & Kitamura, N. (1991). An alternatively processed mRNA generated from human hepatocyte growth factor gene. Eur. J. Biochem. 197, 15-22.
22. Chan, A.M., Rubin, J.S., Bottaro, D.P., Hirschfield, D.W., Chedid, M. & Aaronson, S.A. (1991). Identification of a competitive HGF antagonist encoded by an alternative transcript. Science 254, 1382-1385.
23. Lokker, N.A & Godowski, P.J. (1993). Generation and characterization of a competitive antagonist of human hepatocyte growth factor, HGF/NK1. J. Biol. Chem. 268, 17145-17150.
24. Cioce, V., et al., & Rubin, J.S. (1996). Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF/scatter factor variant with partial agonist/antagonist activity. J. Biol. Chem. 271, 13110-13115.
25. Schwall, R.H., et al., & Zioncheck, T.F. (1996). Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2. J. Cell Biol. 133, 709-718.
26. Sakata, H., et al., & Rubin, J.S. (1997). Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling. J. Biol. Chem. 272, 9457-9463.
27. Lokker, N.A., Presta, L.G. & Godowski, P.J. (1994). Mutational analysis and molecular modeling of the N-terminal kringle-containing domain of hepatocyte growth factor identifies amino acid sidechains important for interaction with the c-Met receptor. Protein Eng. 7, 895-903.
28. Mizuno, K., et al., & Nakamura, T. (1994). Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor. J. Biol. Chem. 269, 1131-1136.
29. Zhou, H., et al., & Byrd, R.A. (1998). The solution structure of the N-terminal domain of the hepatocyte growth factor reveals a potential heparin-binding site. Structure 6, 109-116.
30. Laskowski, R.A., MacArthur, M.W., Moss, D.S. & Thornton, J.M. (1993). Procheck: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283-291.
31. Morris, A.L., MacArthur, M.W., Hutchinson, E.G. & Thornton, J.M. (1992). Stereochemical quality of protein structure coordinates. Proteins 12, 345-364.
32. De Vos, A.M., et al., & Kossiakoff, A.A. (1992). Crystal structure of the kringle-2 domain of tissue plasminogen activator at 2.4 Å resolution. Biochemistry 31, 270-279.
33. Mulichak, A.M., Tulinsky, A. & Ravichandran, K.G. (1991). Crystal and molecular structure of the human plasminogen kringle 4 refined at 1.9 Å resolution. Biochemistry 30, 10576-10588.
34. Wu, T.-P., Padmanabhan, K., Tulinsky, A. & Mulichak, A.M. (1991). The refined structure of the ε-aminocaproic acid complex of human plasminogen kringle 4. Biochemistry 30, 10589-10594.
35. Jancarik, J. & Kim, S.-H. (1991). Sparse matrix sampling: a screening method for crystallization of proteins. J. Appl. Crystallogr. 24, 409-411.
36. Matthews, B.W. (1968). Solvent content of protein crystals. J. Mol. Biol. 33, 491-497.
37. Messerschmidt, A. & Pflugrath, J.W. (1987). Crystal orientation and X-ray pattern prediction routines for area-detector diffractometer systems in macromolecular crystallography. J. Appl. Crystallogr. 20, 306-315.
38. Kabsch, W. (1988). Evaluation of single-crystal X-ray diffraction data from a position sensitive detector. J. Appl. Crystallogr. 21, 916-924.
39. Otwinowski, Z. (1993). Oscillation data reduction program. In Proceedings of the CCP4 Study Weekend: Data Collection and Processing. (Sawyer, L., Isaacs, N. & Bailey, S., eds.), pp. 56-62, SERC Daresbury Laboratory, UK.
40. Terwilliger, T., Kim, S.-H. & Eisenberg, D. (1987). Generalized method of determining heavy-atom positions using the difference Patterson function. Acta Crystallogr. A43, 1-6.
41. Steigemann, W. (1989). PROTEIN, a program for the crystal structure analysis of proteins. Max-Planck-lnstitut für Biochemie, Markinsreid bei München, Germany.
42. Wang, B.C. (1985). Resolution of phase ambiguity in macromolecular crystallography. Methods Enzymol. 115, 90-112.
43. Jones, A.T. (1985). Interactive computer graphics: FRODO. Methods Enzymol. 115, 157-171.
44. Brünger, A.T., Kuriyan, J. & Karplus, M. (1987). Refinement by simulated annealing. Science 235, 458-460.
45. Engh, R.A. & Huber, R. (1991). Accurate bond and angle parameters for X-ray protein structure refinement. Acta Crystallogr. A 47, 392-400.
46. Brünger, A.T. (1992). Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355, 472-475.
47. Read, R.J. (1986). Improved fourier coefficients for maps using phases from partial structures with error. Acta Crystallogr. A 42, 140-149.
48. Brünger, A.T., Krukowski, A. & Erickson, J.W. (1990). Slow cooling protocols for crystallographic refinement by simulated annealing. Acta Crystallogr. A 46, 585-593.
49. Kraulis, P.J. (1991). MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950.
50. Merritt, E.A. & Murphy, M.E.P. (1994). RASTER 3D version 2.0, a program for photorealistic molecular graphics. Acta Crystallogr. D 50, 869-873.
51. Nicholls, A., Bharadwaj, R. & Honig, B. (1993). GRASP: graphical representation and analysis of surface properties. Biophys. J. 64, 166-170.